ISSN: 1521-298X

Journal Home

Journal Guideline

Dissolution Technologies Q3 Unclaimed

Dissolution Technologies Inc United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Dissolution Technologies is a journal indexed in SJR in Pharmaceutical Science with an H index of 36. It has an SJR impact factor of 0,218 and it has a best quartile of Q3. It has an SJR impact factor of 0,218.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Pharmaceutical Science (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,218

SJR Impact factor

36

H Index

27

Total Docs (Last Year)

69

Total Docs (3 years)

806

Total Refs

61

Total Cites (3 years)

65

Citable Docs (3 years)

0.9

Cites/Doc (2 years)

29.85

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Journal of Biomedical Nanotechnology Q3
Journal of Pharmacy Technology Q3
Jordan Journal of Pharmaceutical Sciences Q3
Open Medicinal Chemistry Journal Q3
Journal of Advanced Pharmaceutical Technology and Research Q3

Compare this journals

Aims and Scope

Best articles by citations

Albendazole Solid Dispersions: Influence of Dissolution Medium Composition on In Vitro Drug Release

Formulation and Characterization of Floating Gelucire Matrices of Metoprolol Succinate

Differences in In Vitro Dissolution Rates Using Single-Point and Multi-Point Sampling

Evaluation of Glass Dissolution Vessel Dimensions and Irregularities

A Comparative In Vitro Assay of Drug Release Performance of Pyridostigmine Bromide Tablets

Improved Hydrodynamics for USP Apparatus 2

Development of Discriminating Method for Dissolution of Aceclofenac Marketed Formulations

A Discriminatory and Biorelevant Dissolution Test Method for Simvastatin Drug Products

IVIVC: Methods and Applications in Modified-Release Product Development

Assessmant of the Physicochemical Properties and In Vitro Dissolution of Glibenclamide Tablets Marketed in Saudi Arabia

Dissolution Enhancement and Physicochemical Characterization of Valsartan in Solid Dispersions with beta-CD, HP beta-CD, and PVP K-30

Physicochemical Characterization and Dissolution Study of Solid Dispersions of Furosemide with Polyethylene Glycol 6000 and Polyvinylpyrrolidone K30

SHOW MORE ARTICLES

Dissolution Highlights of the AAPS Annual Meeting

Book Review Dissolution Theory, Methodology, and Testing

Product Performance Test for Medicated Chewing Gums

Effect of Paddle-Shaft Position on the Dissolution Rate of Sodium Diclofenac Tablets and the Equivalence Assessment of a Generic Product

Practical Considerations for the Development of a Robust Two-Step Dissolution Test for Enteric-Coated Immediate- and Extended-Release Solid Oral Dosage Formulations

Investigation of the Dissolution Characteristics of Nifedipine Extended-Release Formulations Using USP Apparatus 2 and a Novel Dissolution Apparatus

Proposed Change to Acceptance Criteria for Dissolution Performance Verification Testing

In Vitro Release of Indian Penny Wort, Walnut, and Turmeric from Topical Preparations Using Two Different Types of Membranes

Dissolution Stability Study of Cefadroxil Extemporaneous Suspensions

Investigation of the Effect of Different Flow-Through Cell Designs on the Release of Diclofenac Sodium SR Tablets

Proposed Design of a Dissolution Apparatus for Vaginal Formulations Containing Probiotics

An Approach for Improvement of the Dissolution Rate of Gliclazide